Lipscomb Joseph, Donaldson Molla S
Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892-7344, USA.
Clin Ther. 2003 Feb;25(2):699-712. doi: 10.1016/s0149-2918(03)80106-6.
What is the National Cancer Institute (NCI) doing to enhance the state of the science for measuring and understanding patient-centered outcomes of cancer care and to make this information useful for improved decision making? The NCI has a new focus on research that describes, interprets, and predicts the impact of various influences, especially interventions, on end points that matter to decision makers. The research includes end points such as survival, health-related quality of life, satisfaction and patient experience, and economic burden. To further this work, NCI supports and conducts research to (1) identify valid, reliable, responsive, and feasible end-point measures; (2) collect high-quality evidence about the impact of interventions on the end points of interest; (3) improve our understanding of the effects of other factors that shape this interaction; and (4) expand our capacity to translate research findings into information that is useful to patients, clinical policy makers, payers, regulators, standard setters, and providers of cancer care.
美国国立癌症研究所(NCI)正在采取哪些措施来提升衡量和理解以患者为中心的癌症治疗结果的科学水平,并使这些信息有助于改善决策?NCI 对一项新研究重点关注,该研究描述、解释并预测各种影响因素,尤其是干预措施,对决策者所关注的终点指标的影响。该研究涵盖的终点指标包括生存率、健康相关生活质量、满意度和患者体验以及经济负担。为推动这项工作,NCI 支持并开展研究,以(1)确定有效、可靠、灵敏且可行的终点指标测量方法;(2)收集关于干预措施对所关注终点指标影响的高质量证据;(3)增进我们对塑造这种相互作用的其他因素影响的理解;(4)扩大我们将研究成果转化为对癌症患者、临床政策制定者、支付方、监管机构、标准制定者及癌症护理提供者有用信息的能力。